ReleaseWire Connect

The Australian commercial real estate market continues to be fairly balanced because, structurally, the industry functions in a way that restricts over-development. It operates in an economy that, despite weak consumer sentiment and structural changes, is performing reasonably well. The economy and sector are underpinned by resources and demand from China, a reducing threat of interest rate rises, low unemployment and a strong infrastructure sector. We caution, however, that our outlook for the economy in 2012 is bearish, and the country will be negatively affected by the expected slowdown in Chinese economic growth.

We expect the mining sector will recover from the lower production of 2011 (caused by strikes and falling ore grades) as several mining projects begin initial production in 2012. We forecast Chile's mining sector growth to come in at 9.1% year-on-year (y-o-y) in 2012. We have revised our industry growth forecasts due to rising risks which we believe will delay mine projects. We expect the bulk of the industry growth to come in 2014 and 2015 as multiple projects come online around the same time. We forecast average annual growth over our 2012-2016 forecast period to be 6.8% with the mining industry reaching a value of US$46.5bn in 2016.

Even though its population falls short of the 18mn mark, Chile leapfrogged Brazil to top our Latin America Risk/Reward Ratings matrix for Q312. Despite some economic growth uncertainties posed by slower growth in its main export partners, Chile's positive short- to medium-term consumer demand story remains in play. However, the country's modest youth population component and the maturing food and drink market indicate challenges ahead which are expected to moderate its annual growth rates.

GlobalData's clinical trial report, "Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2012" provides data on the Peripheral Neuropathy (Sensory Neuropathy) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Peripheral Neuropathy (Sensory Neuropathy). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Peripheral Neuropathy (Sensory Neuropathy). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

The non-small cell lung cancer pipeline is growing as a result of an increased understanding of the disease's heterogeneity, which has led to the development of personalized therapies targeting distinct patient subtypes. The success of these personalized therapies is likely to incentivize pharmaceutical companies to continue developing targeted therapies for niche patient populations.

New therapies have entered the benign prostatic hyperplasia (BPH) drug market since Datamonitor reviewed the market in 2009, including Rapaflo (silodosin; Recordati) and Duodart/Jalyn (dutasteride and tamsulosin; GlaxoSmithKline). Meanwhile, the failure of AEterna Zentaris's cetrorelix to meet Phase III efficacy endpoints signals the end of gonadotropin-releasing hormones being approved for BPH.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

This global package contains all of our 87 cheese market analyses from the following countries around the world: Albania, Argentina, Armenia, Australia, Austria, Azerbaijan, Bangladesh, Belgium, Bolivia, Botswana, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Denmark, Ecuador, Egypt, Eritrea, Estonia, Ethiopia, Finland, France, Georgia, Germany, Ghana, Greece, Hungary, India, Indonesia, Iran, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kenya, Kyrgyzstan, Latvia, Lebanon, Lithuania, Macedonia, Malaysia, Mexico, Moldova, Mongolia, Morocco, Nepal, Netherlands, New Zealand, Norway, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Rwanda, Senegal, Sierra Leone, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sri Lanka, Sudan, Sweden, Tajikistan, Tanzania, Thailand, Turkey, Turkmenistan, Ukraine, United Kingdom, United States, Uruguay and Vietnam.

"Global Packaging Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global PackagingIndustry" is a new report by Canadean that analyzes how packaging companies' media spend, marketing and sales strategies and practices, and business planning, are set to change in 2012-2013. This report provides the current size of the marketing and advertising budgets of global packaging suppliers and how spending by suppliers will change, providing insight into global marketing behavior. In addition, the report identifies future growth of buyers and suppliers, and M&A activity. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type, and size.

This report provides projections of the volume and wealth of Brazilian HNWIs and a comprehensive background of the local economy. This includes demographic trends (2007-2011) and findings of the proprietary WealthInsight HNWI Database.